A detailed history of Simon Quick Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Simon Quick Advisors, LLC holds 6,699 shares of NVO stock, worth $703,796. This represents 0.05% of its overall portfolio holdings.

Number of Shares
6,699
Previous 5,867 14.18%
Holding current value
$703,796
Previous $837,000 4.78%
% of portfolio
0.05%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$119.07 - $145.42 $99,066 - $120,989
832 Added 14.18%
6,699 $797,000
Q2 2024

Aug 02, 2024

BUY
$122.71 - $146.91 $69,944 - $83,738
570 Added 10.76%
5,867 $837,000
Q1 2024

Apr 19, 2024

BUY
$102.11 - $135.92 $221,374 - $294,674
2,168 Added 69.29%
5,297 $680,000
Q4 2023

Jan 16, 2024

SELL
$87.78 - $105.45 $85,409 - $102,602
-973 Reduced 23.72%
3,129 $323,000
Q3 2023

Oct 24, 2023

BUY
$90.94 - $199.54 $196,703 - $431,605
2,163 Added 111.55%
4,102 $373,000
Q2 2023

Aug 01, 2023

BUY
$155.98 - $172.65 $10,138 - $11,222
65 Added 3.47%
1,939 $313,000
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $248,005 - $298,228
1,874 New
1,874 $298,000
Q4 2020

Jan 27, 2021

SELL
$63.89 - $73.8 $26,003 - $30,036
-407 Closed
0 $0
Q3 2020

Oct 26, 2020

BUY
$63.69 - $70.22 $25,921 - $28,579
407 New
407 $28,000
Q1 2020

Apr 09, 2020

SELL
$49.46 - $64.78 $45,750 - $59,921
-925 Closed
0 $0
Q4 2019

Jan 06, 2020

BUY
$49.86 - $58.26 $40,685 - $47,540
816 Added 748.62%
925 $54,000
Q3 2019

Oct 16, 2019

BUY
$47.54 - $53.43 $2,804 - $3,152
59 Added 118.0%
109 $6,000
Q2 2019

Aug 05, 2019

BUY
$46.79 - $52.47 $2,339 - $2,623
50 New
50 $0
Q4 2018

Jan 29, 2019

SELL
$41.54 - $47.25 $4,860 - $5,528
-117 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$47.53 - $53.73 $5,561 - $6,286
117
117 $6,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Simon Quick Advisors, LLC Portfolio

Follow Simon Quick Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simon Quick Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simon Quick Advisors, LLC with notifications on news.